Nexeon MedSystems Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Nexeon MedSystems Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011412
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nexeon MedSystems Inc (Nexeon) is a bioelectronics company that develops and commercializes therapies and devices for the treatment of cardiovascular diseases. The company’s products categories include nanotechnology-based devices, embolic protection systems, local drug and biologic delivery systems, and cell delivery and regenerative therapy devices in various stages of development. It develops anatomy-specific combination embolic protection and stent delivery systems for endovascular procedures. The company develops cell delivery and regenerative therapies for delivery of stem cells and biologics to target end-organ sites in order to treat conditions such as chronic congestive heart failure, chronic critical limb ischemia and acute myocardial infarction. Nexeon is headquartered in Dallas, Texas, the US.

Nexeon MedSystems Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nexeon MedSystems Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Nexeon MedSystems Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Nexeon MedSystems Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Nexeon MedSystems Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Nexeon MedSystems Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Nexeon MedSystems Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Nexeon MedSystems Raises USD0.1 Million in Venture Financing 10
Nexeon Medsystems Raises Private Round of Funding 11
Nexeon MedSystems Raises USD1.3 Million in Financing 12
Partnerships 13
Nexeon MedSystems Enters into Licensing Agreement with William Rosellini 13
Equity Offering 14
Nexeon MedSystems to Raise Funds in Private Placement of Shares 14
Acquisition 15
Nexeon MedSystems Acquires Nexeon Medsystems Belgium from Rosellini Scientific 15
Nexeon Medsystems Belgium Acquires Medi-Line 16
Nexeon MedSystems Inc – Key Competitors 17
Nexeon MedSystems Inc – Key Employees 18
Nexeon MedSystems Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Legal and Regulatory 20
Sep 28, 2017: Nexeon MedSystems Begins Trading as NXNN 20
Other Significant Developments 21
Aug 08, 2017: Nexeon Receives Research Grant from National Institutes of Health 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Nexeon MedSystems Inc, Medical Equipment, Key Facts 2
Nexeon MedSystems Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Nexeon MedSystems Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Nexeon MedSystems Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Nexeon MedSystems Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Nexeon MedSystems Inc, Deals By Market, 2011 to YTD 2017 8
Nexeon MedSystems Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Nexeon MedSystems Raises USD0.1 Million in Venture Financing 10
Nexeon Medsystems Raises Private Round of Funding 11
Nexeon MedSystems Raises USD1.3 Million in Financing 12
Nexeon MedSystems Enters into Licensing Agreement with William Rosellini 13
Nexeon MedSystems to Raise Funds in Private Placement of Shares 14
Nexeon MedSystems Acquires Nexeon Medsystems Belgium from Rosellini Scientific 15
Nexeon Medsystems Belgium Acquires Medi-Line 16
Nexeon MedSystems Inc, Key Competitors 17
Nexeon MedSystems Inc, Key Employees 18
Nexeon MedSystems Inc, Subsidiaries 19

★海外企業調査レポート[Nexeon MedSystems Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Darden Restaurants, Inc. (DRI):企業の財務・戦略的SWOT分析
    Darden Restaurants, Inc. (DRI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Cytodyn Inc (CYDY):企業の財務・戦略的SWOT分析
    Summary Cytodyn Inc (Cytodyn) is a clinical-stage biotechnology company focused on the clinical development and potential commercialization of humanized monoclonal antibodies for the treatment of Human Immunodeficiency Virus (HIV) infections. Its pipeline products include Leronlimab (PRO 140), a ful …
  • Kenya Electricity Generating Co Ltd:発電所・企業SWOT分析
    Kenya Electricity Generating Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Samsung Securities Co Ltd (016360):企業の財務・戦略的SWOT分析
    Samsung Securities Co Ltd (016360) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • ResApp Health Ltd (RAP):製薬・医療:M&Aディール及び事業提携情報
    Summary ResApp Health Ltd (ResApp) formerly, Narhex Life Sciences Limited is a digital health company that develops smartphone applications for the diagnosis and management of respiratory disease. It's digital healthcare solutions assist doctors and patients to diagnose and manage respiratory diseas …
  • CellaVision AB (CEVI):医療機器:M&Aディール及び事業提携情報
    Summary CellaVision AB (CellaVision) is a medical technology company that provides digital solutions for medical microscopy in hematology. The company helps hematology laboratories improve and transform the analysis of blood and other body fluids. It has expertise in digital image analysis, automate …
  • The Middleby Corporation (MIDD):企業の財務・戦略的SWOT分析
    The Middleby Corporation (MIDD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Fomento de Construcciones y Contratas S.A.:戦略・SWOT・企業財務分析
    Fomento de Construcciones y Contratas S.A. - Strategy, SWOT and Corporate Finance Report Summary Fomento de Construcciones y Contratas S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Premier Farnell Ltd:企業の戦略的SWOT分析
    Premier Farnell Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Progenity Inc:医療機器:M&Aディール及び事業提携情報
    Summary Progenity, Inc. (Progenity) is a US based company engaged in providing specialized diagnostic and complex molecular tests to clinicians. The company offers molecular and diagnostic testing for inheritable cancer, pre-eclampsia and genetic disorders to children and women. It also provides ser …
  • Banco Santander SA:戦略・SWOT・企業財務分析
    Banco Santander SA - Strategy, SWOT and Corporate Finance Report Summary Banco Santander SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Haisco Pharmaceutical Group Co Ltd (002653)-製薬・医療分野:企業M&A・提携分析
    Summary Haisco Pharmaceutical Group Co Ltd (Haisco Pharma), formerly Xizang Haisco Pharmaceutical Group Co Ltd is a developer and marketer of chemical drug preparations and bulk drugs. The company's product portfolio comprises injection for trace elements, compound vitamin, invert sugar, fat soluble …
  • GE Healthcare LLC-医療機器分野:企業M&A・提携分析
    Summary GE Healthcare LLC (GE Healthcare) a business unit of General Electric Company, is a global medical device provider that designs, develops, manufactures, and distributes diagnostic imaging and clinical systems; products and services for drug discovery, biopharmaceutical manufacturing and cell …
  • Panoro Energy ASA (PEN):企業の財務・戦略的SWOT分析
    Summary Panoro Energy ASA (Panoro) is an independent oil and gas exploration and development company that explores, develops and produces oil and gas properties in Brazil and West Africa. It holds interests in production and exploration assets in Santos and Camamu Almada basins in Brazil. It also ho …
  • Abu Dhabi Commercial Bank P.J.S.C.:戦略・SWOT・企業財務分析
    Abu Dhabi Commercial Bank P.J.S.C. - Strategy, SWOT and Corporate Finance Report Summary Abu Dhabi Commercial Bank P.J.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Hudbay Minerals Inc:企業の戦略・SWOT・財務分析
    Hudbay Minerals Inc - Strategy, SWOT and Corporate Finance Report Summary Hudbay Minerals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • PanaHome Corp:企業の戦略的SWOT分析
    PanaHome Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • BioPorto Diagnostics AS:医療機器:M&Aディール及び事業提携情報
    Summary BioPorto Diagnostics AS (BioPorto Diagnostics), formerly AntibodyShop AS is an in-vitro diagnostics company that manufactures and markets antibodies and antibody based products. The company’s products include matched reagent set, immunoassays, antigens, antibodies, controls calibrators and m …
  • OpGen Inc (OPGN):医療機器:M&Aディール及び事業提携情報
    Summary OpGen Inc (OpGen) is a molecular diagnostics company that harnesses genomic analysis and bioinformatics to prevent the threat of antibiotic resistance and multi drug resistant organisms (MDROs). The company’s clinical laboratory services include high resolution microbial sequence analysis, s …
  • Bunge Ltd (BG):企業の財務・戦略的SWOT分析
    Bunge Ltd (BG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆